Product Code: ETC067184 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Thailand liquid biopsy market is projected to experience significant growth in the coming years. Liquid biopsy refers to a non-invasive medical test that analyzes a patient`s blood sample to detect and monitor various conditions, including cancer and infectious diseases. The market`s expansion is driven by the increasing adoption of liquid biopsy techniques as a reliable and less invasive diagnostic tool.
One of the key drivers of the Thailand liquid biopsy market is the growing prevalence of cancer and the need for early and accurate cancer detection. Liquid biopsy offers the advantage of detecting tumor-related biomarkers in the bloodstream, enabling early cancer diagnosis and monitoring treatment responses. Moreover, advancements in molecular diagnostics and genetic testing technologies enhance the sensitivity and specificity of liquid biopsy tests, further driving their adoption. Additionally, the rising awareness of the importance of preventive healthcare and regular screenings contributes to the demand for liquid biopsy as a valuable diagnostic tool.
The Thailand liquid biopsy market faces challenges related to reimbursement and regulatory considerations. Reimbursement policies for liquid biopsy tests may vary, affecting their accessibility to patients. Another challenge is the need for standardization and validation of liquid biopsy technologies to ensure consistent and reliable results.
The Covid-19 pandemic had an impact on the Thailand liquid biopsy market. During the pandemic, disruptions in healthcare services and the focus on Covid-19 testing may have temporarily affected the adoption of liquid biopsy tests for other medical conditions. However, as healthcare services resume and the importance of non-invasive diagnostic solutions remains evident, the demand for liquid biopsy is expected to rebound. The versatility and potential applications of liquid biopsy in various medical fields make it a valuable tool in the post-pandemic period.
Key players in the Thailand liquid biopsy market play a critical role in providing innovative liquid biopsy technologies and solutions. Some key players in the market include Biocept Inc., Guardant Health, Inc., and QIAGEN N.V. These companies offer a range of liquid biopsy tests, including circulating tumor DNA (ctDNA) analysis and cell-free DNA (cfDNA) testing, to meet the diverse diagnostic needs of patients and healthcare providers. As the demand for non-invasive and accurate diagnostic solutions continues to grow, these key players are expected to remain influential in shaping the liquid biopsy market in the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Liquid Biopsy Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Liquid Biopsy Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Liquid Biopsy Market - Industry Life Cycle |
3.4 Thailand Liquid Biopsy Market - Porter's Five Forces |
3.5 Thailand Liquid Biopsy Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Thailand Liquid Biopsy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Thailand Liquid Biopsy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Thailand Liquid Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Thailand Liquid Biopsy Market Trends |
6 Thailand Liquid Biopsy Market, By Types |
6.1 Thailand Liquid Biopsy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Thailand Liquid Biopsy Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Thailand Liquid Biopsy Market Revenues & Volume, By Handheld Instruments, 2021-2031F |
6.1.4 Thailand Liquid Biopsy Market Revenues & Volume, By Inflation Devices, 2021-2031F |
6.1.5 Thailand Liquid Biopsy Market Revenues & Volume, By Guiding Devices, 2021-2031F |
6.1.6 Thailand Liquid Biopsy Market Revenues & Volume, By Electrosurgical & Electrocautery Instruments, 2021-2031F |
6.1.7 Thailand Liquid Biopsy Market Revenues & Volume, By Others, 2021-2031F |
6.2 Thailand Liquid Biopsy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Thailand Liquid Biopsy Market Revenues & Volume, By Clinical Application, 2021-2031F |
6.2.3 Thailand Liquid Biopsy Market Revenues & Volume, By Non-clinical Application, 2021-2031F |
6.3 Thailand Liquid Biopsy Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Thailand Liquid Biopsy Market Revenues & Volume, By Hospitals, 2021-2031F |
6.3.3 Thailand Liquid Biopsy Market Revenues & Volume, By Academic & Research Centers, 2021-2031F |
6.3.4 Thailand Liquid Biopsy Market Revenues & Volume, By Others, 2021-2031F |
7 Thailand Liquid Biopsy Market Import-Export Trade Statistics |
7.1 Thailand Liquid Biopsy Market Export to Major Countries |
7.2 Thailand Liquid Biopsy Market Imports from Major Countries |
8 Thailand Liquid Biopsy Market Key Performance Indicators |
9 Thailand Liquid Biopsy Market - Opportunity Assessment |
9.1 Thailand Liquid Biopsy Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Thailand Liquid Biopsy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Thailand Liquid Biopsy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Thailand Liquid Biopsy Market - Competitive Landscape |
10.1 Thailand Liquid Biopsy Market Revenue Share, By Companies, 2024 |
10.2 Thailand Liquid Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |